Christophe Weber, Takeda president and CEO (AP Images)

Take­da gets a $2.2B deal for its OTC unit as debt-re­lief dri­ve nears its end

In a big step to­ward its $10 bil­lion di­vest­ment goal, Take­da struck a deal to sell its Japan­ese con­sumer health­care busi­ness, known for over-the-counter prod­ucts …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.